Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings.

M Richards, T W Meade, S Peart, P J Brennan and A H Mann

Section of Old Age Psychiatry, Institute of Psychiatry, London, UK.

To explore whether antithrombotic medication may protect against cognitive decline, tests of verbal memory, attention, abstract reasoning, verbal fluency, and mental flexibility were administered to 405 men at risk of cardiovascular disease. These subjects were a subgroup of those who had been participating in a randomised double blind factorial trial of low dose aspirin (75 mg daily) and low intensity oral anticoagulation with warfarin (international normalised ratio of 1.5) at 35 general practices across the United Kingdom for at least five years, were at least 55 years old at trial entry, and had been randomly allocated to one of four groups: active warfarin and active aspirin, active warfarin and placebo aspirin, placebo warfarin and active aspirin, and double placebo. Verbal fluency and mental flexibility were significantly better in subjects taking antithrombotic medication than in subjects taking placebo. Aspirin may have contributed more than warfarin to any beneficial effect. These results provide tentative evidence that antithrombotic medication may protect cognitive function in men at risk of cardiovascular disease.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Strachan, M. W. J., Reynolds, R. M., Frier, B. M., Mitchell, R. J., Price, J. F. (2008). The relationship between type 2 diabetes and dementia. Br Med Bull 88: 131-146 [Abstract] [Full Text]  
• Price, J. F, Stewart, M. C, Deary, I. J, Murray, G. D, Sandercock, P., Butcher, I., Fowkes, F G. R, on behalf of the AAA Trialists, (2008). Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. BMJ 337: a1198-a1198 [Abstract] [Full Text]  
• Kang, J. H., Cook, N., Manson, J., Buring, J. E, Grodstein, F. (2007). Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ 334: 987-987 [Abstract] [Full Text]  
• Dentali, F., Douketis, J. D., Lim, W., Crowther, M. (2007). Combined Aspirin-Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease: A Meta-analysis of Randomized Trials. Arch Intern Med 167: 117-124 [Abstract] [Full Text]  
• Schillerstrom, J. E., Horton, M. S., Royall, D. R. (2005). The Impact of Medical Illness on Executive Function. Psychosomatics 46: 508-516 [Abstract] [Full Text]  
• McLaurin, E. Y., Holliday, S. L., Williams, P., Brey, R. L. (2005). Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 64: 297-303 [Abstract] [Full Text]  
• Werring, D. J., Frazer, D. W., Coward, L. J., Losseff, N. A., Watt, H., Cipolotti, L., Brown, M. M., Jager, H. R. (2004). Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 127: 2265-2275 [Abstract] [Full Text]  
• Hee Kang, J., Grodstein, F. (2003). Regular use of nonsteroidal anti-inflammatory drugs and cognitive function in aging women. Neurology 60: 1591-1597 [Abstract] [Full Text]  
• Kumari, M., Brunner, E., Fuhrer, R. (2000). Minireview: Mechanisms by Which the Metabolic Syndrome and Diabetes Impair Memory. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 55: 228B-232 [Abstract] [Full Text]  
• van Kooten, F., Ciabattoni, G., Koudstaal, P. J., Grobbee, D. E., Kluft, C., Patrono, C. (1999). Increased Thromboxane Biosynthesis Is Associated With Poststroke Dementia. Stroke 30: 1542-1547 [Abstract] [Full Text]  
• Rozzini, R., Sabatini, T., Trabucchi, M., Kilander, L., Boberg, M. (1999). Chronic Atrial Fibrillation and Low Cognitive Function • Response. Stroke 30: 190-191 [Full Text]